TITLE

Randomized Trial of Cefepime Monotherapy or Cefepime in Combination with Amikacin as Empirical Therapy for Febrile Neutropenia

AUTHOR(S)
Tamura, K.; Imajo, K.; Akiyama, N.; Suzuki, K.; Urabe, A.; Ohyashiki, K.; Tanimoto, M.; Masaoka, T.
PUB. DATE
July 2004
SOURCE
Clinical Infectious Diseases;7/15/2004 Supplement 1, Vol. 39, pS15
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
A multicenter open randomized trial was conducted to compare cefepime monotherapy with cefepime/amikacin combination (dual) therapy in treating febrile neutropenic patients with hematologic disorders. Among the 189 evaluable patients, 5.8% had microbiologically and 10.6% had clinically documented infections. Excellent response was seen in 32.6% and 45.7% of monotherapy and dual therapy recipients, respectively, at day 3 (P = .065). At day 3, patients with neutrophil counts of <500/μL receiving dual therapy had a better response than did those receiving monotherapy (45% vs. 27.6%; P = .024). The same was true for patients with leukemia. Adverse events were minimal, and early death was observed in 7 patients in the dual therapy group and 5 patients in the monotherapy group. Overall, cefepime monotherapy is as effective as dual therapy for the initial treatment of febrile neutropenic patients. Further study is warranted for patients with severe neutropenia and leukemia who may benefit from dual therapy.
ACCESSION #
23179544

 

Related Articles

  • Monotherapy versus Dual Therapy Based on Risk Categorization of Febrile Neutropenic Patients. Ohyashiki, K. // Clinical Infectious Diseases;7/1/2004 Supplement 1, Vol. 39, pS56 

    Cefepime monotherapy was compared with cefepime-plus-amikacin dual therapy for treatment of febrile neutropenic patients. Response rates were significantly lower for patients receiving monotherapy who had neutrophil counts of <500 cells/mm³ but did not differ significantly between patients...

  • Septic shock and chemotherapy-induced cytopenia: effects on microcirculation. Karvunidis, Thomas; Chvojka, Jiri; Lysak, Daniel; Sykora, Roman; Krouzecky, Ales; Radej, Jaroslav; Novak, Ivan; Matejovic, Martin // Intensive Care Medicine;Aug2012, Vol. 38 Issue 8, p1336 

    Purpose: Neutrophil and platelet activation and their interactions with endothelial cells are considered central features of sepsis-induced microcirculatory alterations. However, no study has evaluated the microvascular pattern of septic shock patients with chemotherapy-induced severe cytopenia....

  • Randomized Trial of Cefepime Monotherapy or Cefepime in Combination with Amikacin as Empirical Therapy for Febrile Neutropenia. Tamura, K.; Imajo, K.; Akiyama, N.; Suzuki, K.; Urabe, A.; Ohyashiki, K.; Tanimoto, M.; Masaoka, T. // Clinical Infectious Diseases;7/1/2004 Supplement 1, Vol. 39, pS15 

    A multicenter open randomized trial was conducted to compare cefepime monotherapy with cefepime/amikacin combination (dual) therapy in treating febrile neutropenic patients with hematologic disorders. Among the 189 evaluable patients, 5.8% had microbiologically and 10.6% had clinically...

  • Diagnóstico de Aspergillosis en pacientes con enfermedad hematológica. Morelli, Josefina; Bardossy, Ana C.; Marianelli, Leonardo; Frassone, Natalia; Zarate, Abel H. // Revista Experiencia Médica;2010, Vol. 28 Issue 1, p33 

    Aspergillus is a fungus widely distributed in nature; infections occur mainly in patients with prolonged neutropenia, and the mortality rate can reach 90%in patients with allogenic bone marrow transplantation2. The severe immunocompromise of bone marrow transplanted patients and those with...

  • Positive impact of selective outpatient management of high-risk acute myelogenous leukemia on the incidence of septicemia. TY Halim; KW Song; MJ Barnett; DL Forrest; DE Hogge; SH Nantel; TJ Nevill; JD Shepherd; CA Smith; HJ Sutherland; CL Toze; JC Lavoie // Annals of Oncology;Jul2007, Vol. 18 Issue 7, p1246 

    Background: Curative intent chemotherapy for acute myelogenous leukemia (AML) leads to prolonged severe neutropenia, during which patients are highly susceptible to infection. Traditionally these high-risk patients were treated as inpatients. Our center recently implemented a selective...

  • Filgrastim in Patients with Chemotherapy-induced Febrile Neutropenia. Maher, Darryl W.; Liesehke, Graham J.; Green, Michael; Bishop, James; Stuart-Harris, Robin; Wolf, Max; Sheridan, William P.; Kefford, Richard F.; Cebon, Jonathan; Olver, Ian; McKendrick, Joseph; Toner, Guy; Bradstock, Kenneth; Liesehke, Marian; Cruickshank, Scott; Tomita, Dianne K.; Hoffman, Eric W.; Fox, Richard M.; Morstyn, George // Annals of Internal Medicine;10/1/94, Vol. 121 Issue 7, p492 

    Determines if filgrastim used in addition to standard inpatient antibiotic therapy accelerated recovery from infection associated with chemotherapy-induced neutropenia. Correlation between the degree and duration of neutropenia and the risk for sepsis; Effectiveness of filgrastim therapy;...

  • Isolation of Streptobacillus moniliformis from the blood of a child with acute lymphoblastic leukaemia. De, A. S.; Baveja, S. M.; Salunke, P. M.; Manglani, M. V. // Indian Journal of Medical Microbiology;Oct2010, Vol. 28 Issue 4, p387 

    This is an unusual report of isolation of Streptobacillus moniliformis from the blood of a male child with acute lymphoblastic leukaemia. No history of rat bite was there, but rats were present in the house. The possible source of infection may be food or water contaminated with rat excreta....

  • Hematogones in the Peripheral Blood of a 5½- Month-Old Boy with Cyclic Neutropenia Due to Heterozygous, Novel ELANE Gene Mutation p.Q97P, c.290 A>C. JURANOVIC, TAJANA; O'SUOJI, CHIBUZO C.; SIVAKUMARAN, THERU A.; KEJIAN ZHANG; ESTALLILA, OSCAR C.; JELIC, TOMISLAV M. // Pediatric & Developmental Pathology;Sep/Oct2014, Vol. 17 Issue 5, p393 

    We have identified a novel point mutation in the ELANE gene of a 5.5-month-old boy with severe cyclic neutropenia, and we are reporting for the first time, to our knowledge, the presence of hematogones in the peripheral blood of an infant. The novel point mutation occurred at base number 290 in...

  • neutrophil recovery.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1582 

    A definition of the term "neutrophil recovery," which refers to the return of neutrophil counts to normal in neutropenic patients who have been treated with chemotherapy, is presented.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics